SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired iRhythm Technologies, Inc. (NASDAQ:IRTC) common stock between January 11, 2022 and May 30, 2023. iRhythm is a digital healthcare company that develops and manufactures heart monitoring devices designed to diagnose arrhythmias.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: According to the complaint, during the class period, iRhythm represented to investors that the Zio AT monitor was a real-time monitor intended for a target audience of high-risk patients. The Company's legacy monitor and main product, Zio XT, is a heart monitor intended for non-critical patients, as it does not provide real-time ...
IRTC)>Full story available on Benzinga.com